세계의 기관지내 초음파 생검 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)

The global demand for Endobronchial Ultrasound Biopsy Market is presumed to reach the market size of nearly USD 1142.08 Million by 2032 from USD 694.64 Million in 2023 with a CAGR of 5.68% under the study period 2024-2032.

Endobronchial ultrasound biopsy (EBUS) is a minimally invasive diagnostic procedure used to visualize and biopsy lymph nodes and masses in the chest, particularly in patients with suspected lung cancer. The technique involves using an endobronchial ultrasound scope, which combines bronchoscopy with ultrasound imaging. The scope is inserted through the mouth or nose into the bronchi, allowing real-time visualization of the surrounding structures. Ultrasound waves generated by the device provide detailed images of lymph nodes and other tissues, enabling precise localization and guided biopsy of abnormal areas. This approach offers significant advantages in accuracy, safety, and patient comfort compared to traditional invasive methods, making it an essential tool for early diagnosis and staging of thoracic malignancies.

MARKET DYNAMICS

The endobronchial ultrasound biopsy (EBUS) market is propelled by the increasing incidence of lung cancer globally, which necessitates advanced diagnostic tools for early detection and accurate staging. EBUS offers a minimally invasive alternative to more invasive diagnostic procedures, making it a preferred choice among clinicians for its precision and reduced patient discomfort. Additionally, advancements in EBUS technology, such as improved imaging resolution and enhanced biopsy capabilities, are driving market growth. Innovations like integrating advanced needle guidance systems and real-time imaging enhancements improve diagnostic accuracy and procedural efficiency. Another crucial factor is the rising awareness of early lung cancer detection benefits, boosting demand for EBUS procedures in both developed and emerging markets. The expanding healthcare infrastructure and increasing investments in oncology diagnostics in emerging economies also present significant opportunities for market growth. Moreover, the growing adoption of EBUS in combination with other imaging modalities, such as PET scans, further supports its market expansion by providing comprehensive diagnostic solutions. The ongoing development of next-generation EBUS systems with enhanced features promises to improve patient outcomes and procedural success, driving further adoption and market growth. However, high equipment costs and a shortage of trained professionals can hinder market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Endobronchial Ultrasound Biopsy. The growth and trends of Endobronchial Ultrasound Biopsy industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Endobronchial Ultrasound Biopsy market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Biopsy Forceps
• Cytology Brushes
• Biopsy Needles
• Transbronchial Aspiration Needles
• Spray Catheters
• Others

By Application

• Cancer Diagnosis
• Infection Diagnosis
• Others

By End-user

• Hospitals
• Ambulatory Surgical Centers
• Cancer Specialty Clinics
• Diagnostics Centers
• Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Endobronchial Ultrasound Biopsy market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Endobronchial Ultrasound Biopsy market include Olympus Corporation, Medtronic, Cook Medical, Conmed Corporation, Clinodevice, Medi-Globe GmbH, Boston Scientific Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. ENDOBRONCHIAL ULTRASOUND BIOPSY - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By End-user
  • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY MARKET ANALYSIS BY PRODUCT

• 5.1. Overview By Product
• 5.2. Historical and Forecast Data Analysis By Product
• 5.3. Biopsy Forceps Historic and Forecast Sales By Regions
• 5.4. Cytology Brushes Historic and Forecast Sales By Regions
• 5.5. Biopsy Needles Historic and Forecast Sales By Regions
• 5.6. Transbronchial Aspiration Needles Historic and Forecast Sales By Regions
• 5.7. Spray Catheters Historic and Forecast Sales By Regions
• 5.8. Others Historic and Forecast Sales By Regions

6. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY MARKET ANALYSIS BY APPLICATION

• 6.1. Overview By Application
• 6.2. Historical and Forecast Data Analysis By Application
• 6.3. Cancer Diagnosis Historic and Forecast Sales By Regions
• 6.4. Infection Diagnosis Historic and Forecast Sales By Regions
• 6.5. Others Historic and Forecast Sales By Regions

7. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY MARKET ANALYSIS BY END-USER

• 7.1. Overview By End-user
• 7.2. Historical and Forecast Data Analysis By End-user
• 7.3. Hospitals Historic and Forecast Sales By Regions
• 7.4. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
• 7.5. Cancer Specialty Clinics Historic and Forecast Sales By Regions
• 7.6. Diagnostics Centers Historic and Forecast Sales By Regions
• 7.7. Others Historic and Forecast Sales By Regions

8. GLOBAL ENDOBRONCHIAL ULTRASOUND BIOPSY MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2 North America By Segment Sales Analysis
  • 8.3.3 North America By Country Sales Analysis
  • 8.3.4 United States Sales Analysis
  • 8.3.5 Canada Sales Analysis
  • 8.3.6 Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2 Europe By Segment Sales Analysis
  • 8.4.3 Europe By Country Sales Analysis
  • 8.4.4 United Kingdom Sales Analysis
  • 8.4.5 France Sales Analysis
  • 8.4.6 Germany Sales Analysis
  • 8.4.7 Italy Sales Analysis
  • 8.4.8 Russia Sales Analysis
  • 8.4.9 Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2 Asia Pacific By Segment Sales Analysis
  • 8.5.3 Asia Pacific By Country Sales Analysis
  • 8.5.4 China Sales Analysis
  • 8.5.5 India Sales Analysis
  • 8.5.6 Japan Sales Analysis
  • 8.5.7 South Korea Sales Analysis
  • 8.5.8 Australia Sales Analysis
  • 8.5.9 South East Asia Sales Analysis
  • 8.5.10 Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2 Latin America By Segment Sales Analysis
  • 8.6.3 Latin America By Country Sales Analysis
  • 8.6.4 Brazil Sales Analysis
  • 8.6.5 Argentina Sales Analysis
  • 8.6.6 Peru Sales Analysis
  • 8.6.7 Chile Sales Analysis
  • 8.6.8 Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2 Middle East & Africa By Segment Sales Analysis
  • 8.7.3 Middle East & Africa By Country Sales Analysis
  • 8.7.4 Saudi Arabia Sales Analysis
  • 8.7.5 UAE Sales Analysis
  • 8.7.6 Israel Sales Analysis
  • 8.7.7 South Africa Sales Analysis
  • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE ENDOBRONCHIAL ULTRASOUND BIOPSY COMPANIES

• 9.1. Endobronchial Ultrasound Biopsy Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10. COMPANY PROFILES OF ENDOBRONCHIAL ULTRASOUND BIOPSY INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Olympus Corporation
  • 10.3.1 Company Overview
  • 10.3.2 Company Revenue
  • 10.3.3 Products
  • 10.3.4 Recent Developments
• 10.4. Medtronic
  • 10.4.1 Company Overview
  • 10.4.2 Company Revenue
  • 10.4.3 Products
  • 10.4.4 Recent Developments
• 10.5. Cook Medical
  • 10.5.1 Company Overview
  • 10.5.2 Company Revenue
  • 10.5.3 Products
  • 10.5.4 Recent Developments
• 10.6. Conmed Corporation
  • 10.6.1 Company Overview
  • 10.6.2 Company Revenue
  • 10.6.3 Products
  • 10.6.4 Recent Developments
• 10.7. Clinodevice
  • 10.7.1 Company Overview
  • 10.7.2 Company Revenue
  • 10.7.3 Products
  • 10.7.4 Recent Developments
• 10.8. Medi-Globe GmbH
  • 10.8.1 Company Overview
  • 10.8.2 Company Revenue
  • 10.8.3 Products
  • 10.8.4 Recent Developments
• 10.9. Boston Scientific Corporation
  • 10.9.1 Company Overview
  • 10.9.2 Company Revenue
  • 10.9.3 Products
  • 10.9.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies